

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 9.14665493 |
| 2 | negative T cell selection (GO:0043383) | 9.12787890 |
| 3 | positive thymic T cell selection (GO:0045059) | 8.88928801 |
| 4 | negative thymic T cell selection (GO:0045060) | 8.74788142 |
| 5 | positive T cell selection (GO:0043368) | 7.96904419 |
| 6 | regulation of gamma-delta T cell differentiation (GO:0045586) | 7.23018236 |
| 7 | thymic T cell selection (GO:0045061) | 6.81897742 |
| 8 | regulation of B cell receptor signaling pathway (GO:0050855) | 6.76757981 |
| 9 | positive regulation of isotype switching (GO:0045830) | 6.60908078 |
| 10 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 6.56992856 |
| 11 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 6.56488537 |
| 12 | cellular response to interleukin-15 (GO:0071350) | 6.52838817 |
| 13 | regulation of gamma-delta T cell activation (GO:0046643) | 6.52201734 |
| 14 | response to interleukin-15 (GO:0070672) | 6.14998165 |
| 15 | leukocyte aggregation (GO:0070486) | 6.12721294 |
| 16 | positive regulation of DNA recombination (GO:0045911) | 6.05636596 |
| 17 | T cell selection (GO:0045058) | 6.04865106 |
| 18 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 6.03313823 |
| 19 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 6.03313823 |
| 20 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.84563532 |
| 21 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.84563532 |
| 22 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 5.72499782 |
| 23 | regulation of natural killer cell mediated immunity (GO:0002715) | 5.72499782 |
| 24 | negative regulation of T cell mediated immunity (GO:0002710) | 5.55055993 |
| 25 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.44352824 |
| 26 | cytidine metabolic process (GO:0046087) | 5.41631225 |
| 27 | cytidine catabolic process (GO:0006216) | 5.41631225 |
| 28 | cytidine deamination (GO:0009972) | 5.41631225 |
| 29 | regulation of isotype switching (GO:0045191) | 5.29500751 |
| 30 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 5.27915502 |
| 31 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 5.18735101 |
| 32 | positive regulation of B cell mediated immunity (GO:0002714) | 5.12729120 |
| 33 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 5.12729120 |
| 34 | * T cell migration (GO:0072678) | 5.09439689 |
| 35 | positive regulation of humoral immune response (GO:0002922) | 5.09028865 |
| 36 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 5.04450432 |
| 37 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.03103481 |
| 38 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 5.02718690 |
| 39 | positive regulation of cell killing (GO:0031343) | 4.96875454 |
| 40 | T cell costimulation (GO:0031295) | 4.95274425 |
| 41 | T cell receptor signaling pathway (GO:0050852) | 4.95148908 |
| 42 | interferon-gamma production (GO:0032609) | 4.88829245 |
| 43 | lymphocyte costimulation (GO:0031294) | 4.86831176 |
| 44 | regulation of alpha-beta T cell proliferation (GO:0046640) | 4.84129780 |
| 45 | regulation of cell killing (GO:0031341) | 4.82587212 |
| 46 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 4.60793760 |
| 47 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 4.57137194 |
| 48 | regulation of immunoglobulin mediated immune response (GO:0002889) | 4.54414363 |
| 49 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 4.48718694 |
| 50 | DNA deamination (GO:0045006) | 4.43406183 |
| 51 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 4.41330990 |
| 52 | regulation of T cell tolerance induction (GO:0002664) | 4.40407445 |
| 53 | regulation of B cell mediated immunity (GO:0002712) | 4.40059562 |
| 54 | sequestering of actin monomers (GO:0042989) | 4.38074046 |
| 55 | antigen receptor-mediated signaling pathway (GO:0050851) | 4.30621104 |
| 56 | positive regulation of B cell differentiation (GO:0045579) | 4.28657216 |
| 57 | regulation of T cell mediated cytotoxicity (GO:0001914) | 4.21640550 |
| 58 | positive regulation of immunoglobulin production (GO:0002639) | 4.17971072 |
| 59 | activated T cell proliferation (GO:0050798) | 4.17774153 |
| 60 | regulation of B cell differentiation (GO:0045577) | 4.13777858 |
| 61 | heterotypic cell-cell adhesion (GO:0034113) | 4.06327289 |
| 62 | leukocyte cell-cell adhesion (GO:0007159) | 4.03150202 |
| 63 | immunoglobulin mediated immune response (GO:0016064) | 3.96139903 |
| 64 | B cell receptor signaling pathway (GO:0050853) | 3.82987838 |
| 65 | positive regulation of lymphocyte mediated immunity (GO:0002708) | 3.82142712 |
| 66 | regulation of immunoglobulin production (GO:0002637) | 3.81893648 |
| 67 | regulation of T cell receptor signaling pathway (GO:0050856) | 3.74521597 |
| 68 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.74139830 |
| 69 | type I interferon signaling pathway (GO:0060337) | 3.66595824 |
| 70 | cellular response to type I interferon (GO:0071357) | 3.66595824 |
| 71 | positive regulation of lamellipodium assembly (GO:0010592) | 3.64548077 |
| 72 | response to type I interferon (GO:0034340) | 3.63577959 |
| 73 | regulation of lymphocyte mediated immunity (GO:0002706) | 3.61195288 |
| 74 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.58443543 |
| 75 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 3.57916596 |
| 76 | natural killer cell activation (GO:0030101) | 3.57836700 |
| 77 | regulation of response to interferon-gamma (GO:0060330) | 3.56497746 |
| 78 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 3.52404420 |
| 79 | tolerance induction (GO:0002507) | 3.50695077 |
| 80 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.49408343 |
| 81 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.48793839 |
| 82 | positive regulation of tolerance induction (GO:0002645) | 3.48698349 |
| 83 | T cell differentiation (GO:0030217) | 3.45305672 |
| 84 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.39334551 |
| 85 | B cell mediated immunity (GO:0019724) | 3.38308691 |
| 86 | positive regulation of immune response to tumor cell (GO:0002839) | 3.36518612 |
| 87 | regulation of immune response to tumor cell (GO:0002837) | 3.36518612 |
| 88 | regulation of response to tumor cell (GO:0002834) | 3.36518612 |
| 89 | positive regulation of response to tumor cell (GO:0002836) | 3.36518612 |
| 90 | positive regulation of T cell chemotaxis (GO:0010820) | 3.34101863 |
| 91 | regulation of T cell chemotaxis (GO:0010819) | 3.34101863 |
| 92 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.33993525 |
| 93 | positive regulation of interleukin-4 production (GO:0032753) | 3.32872732 |
| 94 | * lymphocyte migration (GO:0072676) | 3.32687668 |
| 95 | negative regulation of viral genome replication (GO:0045071) | 3.29186225 |
| 96 | positive regulation of calcium-mediated signaling (GO:0050850) | 3.28834826 |
| 97 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 3.27986642 |
| 98 | positive regulation of granulocyte differentiation (GO:0030854) | 3.25678390 |
| 99 | dendritic cell chemotaxis (GO:0002407) | 3.25499970 |
| 100 | alpha-beta T cell activation involved in immune response (GO:0002287) | 3.25407003 |
| 101 | T cell differentiation involved in immune response (GO:0002292) | 3.25407003 |
| 102 | alpha-beta T cell differentiation involved in immune response (GO:0002293) | 3.25407003 |
| 103 | positive regulation of leukocyte mediated immunity (GO:0002705) | 3.25215555 |
| 104 | positive regulation of T cell mediated immunity (GO:0002711) | 3.23710143 |
| 105 | regulation of alpha-beta T cell activation (GO:0046634) | 3.21230429 |
| 106 | T cell proliferation (GO:0042098) | 3.21022515 |
| 107 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.20695733 |
| 108 | negative regulation of T cell apoptotic process (GO:0070233) | 3.19978105 |
| 109 | positive regulation of interleukin-2 production (GO:0032743) | 3.19339450 |
| 110 | detection of bacterium (GO:0016045) | 3.18736597 |
| 111 | * lymphocyte chemotaxis (GO:0048247) | 3.18272871 |
| 112 | myeloid dendritic cell activation (GO:0001773) | 3.17996286 |
| 113 | mast cell activation (GO:0045576) | 3.17978963 |
| 114 | T cell activation (GO:0042110) | 3.17689194 |
| 115 | positive regulation of defense response to virus by host (GO:0002230) | 3.15754684 |
| 116 | NIK/NF-kappaB signaling (GO:0038061) | 3.14842304 |
| 117 | cellular defense response (GO:0006968) | 3.14712293 |
| 118 | negative regulation of adaptive immune response (GO:0002820) | 3.12251051 |
| 119 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.12121498 |
| 120 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.10855902 |
| 121 | regulation of T cell mediated immunity (GO:0002709) | 3.09699414 |
| 122 | positive regulation of T cell activation (GO:0050870) | 3.09680992 |
| 123 | regulation of defense response to virus by virus (GO:0050690) | 3.08361857 |
| 124 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.07871282 |
| 125 | regulation of tolerance induction (GO:0002643) | 3.07830792 |
| 126 | regulation of lymphocyte chemotaxis (GO:1901623) | 3.07035412 |
| 127 | immune response-activating cell surface receptor signaling pathway (GO:0002429) | 3.06790197 |
| 128 | negative regulation of T cell receptor signaling pathway (GO:0050860) | 3.03377159 |
| 129 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.03364775 |
| 130 | regulation of regulatory T cell differentiation (GO:0045589) | 3.01460095 |
| 131 | negative regulation of alpha-beta T cell activation (GO:0046636) | 2.99791314 |
| 132 | positive regulation of lymphocyte migration (GO:2000403) | 2.99518071 |
| 133 | detection of other organism (GO:0098543) | 2.98799365 |
| 134 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 12.6897926 |
| 135 | negative regulation of cell killing (GO:0031342) | 12.6897926 |
| 136 | regulation of isotype switching to IgG isotypes (GO:0048302) | 10.0487576 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 7.66114291 |
| 2 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 6.82031901 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.71142087 |
| 4 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.46819054 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.45293248 |
| 6 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 4.25248150 |
| 7 | RUNX_20019798_ChIP-Seq_JUKART_Human | 4.13739649 |
| 8 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 4.09023839 |
| 9 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 3.64775563 |
| 10 | MYB_26560356_Chip-Seq_TH2_Human | 3.37319009 |
| 11 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.24809020 |
| 12 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.10051037 |
| 13 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.02007194 |
| 14 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.95542149 |
| 15 | MAF_26560356_Chip-Seq_TH1_Human | 2.95540174 |
| 16 | MYB_26560356_Chip-Seq_TH1_Human | 2.75886506 |
| 17 | UTX_26944678_Chip-Seq_JUKART_Human | 2.72794265 |
| 18 | MYC_22102868_ChIP-Seq_BL_Human | 2.69205710 |
| 19 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.60564692 |
| 20 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.43681604 |
| 21 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.32667702 |
| 22 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.20385769 |
| 23 | GATA3_27048872_Chip-Seq_THYMUS_Human | 2.11217786 |
| 24 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.07961191 |
| 25 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.02482464 |
| 26 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.00461390 |
| 27 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.00128027 |
| 28 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.99554997 |
| 29 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.96831022 |
| 30 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.96481686 |
| 31 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.91966827 |
| 32 | MAF_26560356_Chip-Seq_TH2_Human | 1.89558925 |
| 33 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.89347791 |
| 34 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.85686772 |
| 35 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.85209895 |
| 36 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.77423444 |
| 37 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.73862806 |
| 38 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.69969218 |
| 39 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.66017022 |
| 40 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.53544322 |
| 41 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.53044625 |
| 42 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.52109038 |
| 43 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.51958145 |
| 44 | GATA3_26560356_Chip-Seq_TH2_Human | 1.48742049 |
| 45 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.47977456 |
| 46 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.46347117 |
| 47 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.44916881 |
| 48 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.44853150 |
| 49 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.42434826 |
| 50 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.41544994 |
| 51 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.38507416 |
| 52 | SPI1_23127762_ChIP-Seq_K562_Human | 1.30826341 |
| 53 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.29923400 |
| 54 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.29538006 |
| 55 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.29099053 |
| 56 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.27407237 |
| 57 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.26596588 |
| 58 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.22887414 |
| 59 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.21759254 |
| 60 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.21062712 |
| 61 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.20747225 |
| 62 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.20441191 |
| 63 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.19935687 |
| 64 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.16871915 |
| 65 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.14499704 |
| 66 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.14388339 |
| 67 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.13682163 |
| 68 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.10674513 |
| 69 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.10165013 |
| 70 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.09155686 |
| 71 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.08856130 |
| 72 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.07091880 |
| 73 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.06444553 |
| 74 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.05612237 |
| 75 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.04941726 |
| 76 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.04278572 |
| 77 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.02113800 |
| 78 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.99553468 |
| 79 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.96316251 |
| 80 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.95403813 |
| 81 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.91532801 |
| 82 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.90562089 |
| 83 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.87790782 |
| 84 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.87231244 |
| 85 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.84681666 |
| 86 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.84510567 |
| 87 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.83873336 |
| 88 | FLI1_21867929_ChIP-Seq_CD8_Mouse | 0.83788139 |
| 89 | SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 0.83628852 |
| 90 | P300_27268052_Chip-Seq_Bcells_Human | 0.82297125 |
| 91 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 0.81567191 |
| 92 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.81395643 |
| 93 | GATA3_26560356_Chip-Seq_TH1_Human | 0.80984814 |
| 94 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.79438594 |
| 95 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.78412544 |
| 96 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.77928657 |
| 97 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.77657035 |
| 98 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.76379788 |
| 99 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.76316691 |
| 100 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 0.75272161 |
| 101 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.74797364 |
| 102 | GATA1_22025678_ChIP-Seq_K562_Human | 0.74003461 |
| 103 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.73869413 |
| 104 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.73395014 |
| 105 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 0.71983318 |
| 106 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.71959033 |
| 107 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.69753144 |
| 108 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.68932984 |
| 109 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.68198734 |
| 110 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.66745416 |
| 111 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.66299914 |
| 112 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.65583605 |
| 113 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.62492853 |
| 114 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.60541253 |
| 115 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.58535602 |
| 116 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.58463323 |
| 117 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 0.56724772 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003763_abnormal_thymus_physiology | 5.95780486 |
| 2 | MP0006082_CNS_inflammation | 4.99367812 |
| 3 | * MP0005671_abnormal_response_to | 4.90434373 |
| 4 | MP0001835_abnormal_antigen_presentation | 3.61646466 |
| 5 | MP0000685_abnormal_immune_system | 3.56876855 |
| 6 | * MP0009785_altered_susceptibility_to | 3.53875928 |
| 7 | MP0001800_abnormal_humoral_immune | 3.27160545 |
| 8 | MP0005000_abnormal_immune_tolerance | 3.17009526 |
| 9 | MP0009333_abnormal_splenocyte_physiolog | 3.03826985 |
| 10 | * MP0002420_abnormal_adaptive_immunity | 3.00637818 |
| 11 | * MP0001819_abnormal_immune_cell | 2.95304413 |
| 12 | * MP0002723_abnormal_immune_serum | 2.92721178 |
| 13 | * MP0002405_respiratory_system_inflammati | 2.88984388 |
| 14 | * MP0005025_abnormal_response_to | 2.82973321 |
| 15 | MP0001790_abnormal_immune_system | 2.81879696 |
| 16 | MP0005387_immune_system_phenotype | 2.81879696 |
| 17 | MP0002398_abnormal_bone_marrow | 2.75321559 |
| 18 | MP0001873_stomach_inflammation | 2.63854324 |
| 19 | * MP0002452_abnormal_antigen_presenting | 2.59899088 |
| 20 | MP0002166_altered_tumor_susceptibility | 2.53611467 |
| 21 | MP0000716_abnormal_immune_system | 2.48853475 |
| 22 | MP0003724_increased_susceptibility_to | 2.46161510 |
| 23 | MP0002132_abnormal_respiratory_system | 2.45909000 |
| 24 | MP0000703_abnormal_thymus_morphology | 2.43497330 |
| 25 | MP0000858_altered_metastatic_potential | 2.38924141 |
| 26 | MP0002148_abnormal_hypersensitivity_rea | 2.28296952 |
| 27 | MP0002722_abnormal_immune_system | 2.27153260 |
| 28 | MP0002933_joint_inflammation | 2.22939047 |
| 29 | MP0003866_abnormal_defecation | 2.21347869 |
| 30 | MP0000689_abnormal_spleen_morphology | 2.21220670 |
| 31 | MP0002006_tumorigenesis | 2.16070074 |
| 32 | MP0004947_skin_inflammation | 2.14671468 |
| 33 | MP0010155_abnormal_intestine_physiology | 2.09098912 |
| 34 | MP0003436_decreased_susceptibility_to | 2.08231974 |
| 35 | * MP0002419_abnormal_innate_immunity | 2.02485364 |
| 36 | MP0002429_abnormal_blood_cell | 1.98335980 |
| 37 | MP0002396_abnormal_hematopoietic_system | 1.75177296 |
| 38 | * MP0001845_abnormal_inflammatory_respons | 1.72656594 |
| 39 | MP0003300_gastrointestinal_ulcer | 1.61966545 |
| 40 | MP0005464_abnormal_platelet_physiology | 1.59679263 |
| 41 | MP0001851_eye_inflammation | 1.58280432 |
| 42 | MP0004510_myositis | 1.36316191 |
| 43 | MP0002998_abnormal_bone_remodeling | 1.35975945 |
| 44 | * MP0003448_altered_tumor_morphology | 1.34509726 |
| 45 | * MP0002019_abnormal_tumor_incidence | 1.30119392 |
| 46 | MP0002138_abnormal_hepatobiliary_system | 1.27829655 |
| 47 | * MP0008469_abnormal_protein_level | 1.25567502 |
| 48 | MP0004381_abnormal_hair_follicle | 1.23288839 |
| 49 | MP0001853_heart_inflammation | 1.22708846 |
| 50 | MP0001533_abnormal_skeleton_physiology | 1.18846366 |
| 51 | MP0002277_abnormal_respiratory_mucosa | 1.12418432 |
| 52 | MP0003183_abnormal_peptide_metabolism | 1.03420236 |
| 53 | MP0001986_abnormal_taste_sensitivity | 0.99623953 |
| 54 | MP0005310_abnormal_salivary_gland | 0.98558557 |
| 55 | MP0001348_abnormal_lacrimal_gland | 0.98505036 |
| 56 | MP0000465_gastrointestinal_hemorrhage | 0.95958503 |
| 57 | MP0005645_abnormal_hypothalamus_physiol | 0.95702140 |
| 58 | MP0010352_gastrointestinal_tract_polyps | 0.94010503 |
| 59 | * MP0003045_fibrosis | 0.93951934 |
| 60 | MP0000920_abnormal_myelination | 0.91837188 |
| 61 | MP0009763_increased_sensitivity_to | 0.87180951 |
| 62 | MP0005023_abnormal_wound_healing | 0.85709766 |
| 63 | MP0000490_abnormal_crypts_of | 0.83295954 |
| 64 | MP0003693_abnormal_embryo_hatching | 0.82372621 |
| 65 | MP0002163_abnormal_gland_morphology | 0.81994661 |
| 66 | * MP0005166_decreased_susceptibility_to | 0.80434445 |
| 67 | MP0005075_abnormal_melanosome_morpholog | 0.77934493 |
| 68 | MP0004957_abnormal_blastocyst_morpholog | 0.77713721 |
| 69 | MP0008007_abnormal_cellular_replicative | 0.76161383 |
| 70 | MP0009764_decreased_sensitivity_to | 0.76068827 |
| 71 | MP0003077_abnormal_cell_cycle | 0.75370611 |
| 72 | MP0009765_abnormal_xenobiotic_induced | 0.73559988 |
| 73 | MP0001243_abnormal_dermal_layer | 0.72607848 |
| 74 | MP0005058_abnormal_lysosome_morphology | 0.72246341 |
| 75 | MP0000343_altered_response_to | 0.72188370 |
| 76 | MP0003172_abnormal_lysosome_physiology | 0.71682827 |
| 77 | MP0002009_preneoplasia | 0.69917883 |
| 78 | MP0000604_amyloidosis | 0.66484619 |
| 79 | MP0000609_abnormal_liver_physiology | 0.65855484 |
| 80 | MP0008569_lethality_at_weaning | 0.65754014 |
| 81 | MP0000015_abnormal_ear_pigmentation | 0.65202249 |
| 82 | MP0004883_abnormal_blood_vessel | 0.64209367 |
| 83 | * MP0002136_abnormal_kidney_physiology | 0.63267789 |
| 84 | MP0001919_abnormal_reproductive_system | 0.60076399 |
| 85 | MP0003075_altered_response_to | 0.59833454 |
| 86 | MP0003453_abnormal_keratinocyte_physiol | 0.58955792 |
| 87 | MP0003786_premature_aging | 0.56466301 |
| 88 | MP0004808_abnormal_hematopoietic_stem | 0.56309333 |
| 89 | MP0003795_abnormal_bone_structure | 0.56215505 |
| 90 | MP0001191_abnormal_skin_condition | 0.55884003 |
| 91 | MP0002693_abnormal_pancreas_physiology | 0.52968666 |
| 92 | MP0000477_abnormal_intestine_morphology | 0.52789198 |
| 93 | MP0003690_abnormal_glial_cell | 0.52558968 |
| 94 | MP0000613_abnormal_salivary_gland | 0.52382774 |
| 95 | MP0003806_abnormal_nucleotide_metabolis | 0.49059899 |
| 96 | MP0003303_peritoneal_inflammation | 0.48844150 |
| 97 | MP0003191_abnormal_cellular_cholesterol | 0.47065859 |
| 98 | MP0001765_abnormal_ion_homeostasis | 0.45787590 |
| 99 | MP0008058_abnormal_DNA_repair | 0.45258312 |
| 100 | MP0005379_endocrine/exocrine_gland_phen | 0.44798682 |
| 101 | MP0003329_amyloid_beta_deposits | 0.43687589 |
| 102 | MP0001542_abnormal_bone_strength | 0.42842749 |
| 103 | MP0009384_cardiac_valve_regurgitation | 0.41241908 |
| 104 | MP0002095_abnormal_skin_pigmentation | 0.40538440 |
| 105 | MP0003252_abnormal_bile_duct | 0.40428816 |
| 106 | MP0010234_abnormal_vibrissa_follicle | 0.40222954 |
| 107 | MP0002083_premature_death | 0.39962831 |
| 108 | MP0008057_abnormal_DNA_replication | 0.39832491 |
| 109 | MP0001881_abnormal_mammary_gland | 0.39657637 |
| 110 | MP0008872_abnormal_physiological_respon | 0.39425294 |
| 111 | MP0008961_abnormal_basal_metabolism | 0.38236266 |
| 112 | MP0000249_abnormal_blood_vessel | 0.37613666 |
| 113 | * MP0009642_abnormal_blood_homeostasis | 0.37074775 |
| 114 | MP0008873_increased_physiological_sensi | 0.36996784 |
| 115 | * MP0009643_abnormal_urine_homeostasis | 0.36245459 |
| 116 | MP0001216_abnormal_epidermal_layer | 0.35224085 |
| 117 | MP0001663_abnormal_digestive_system | 0.35070139 |
| 118 | MP0005451_abnormal_body_composition | 0.34655492 |
| 119 | MP0010094_abnormal_chromosome_stability | 0.34324661 |
| 120 | MP0005076_abnormal_cell_differentiation | 0.34242793 |
| 121 | MP0005390_skeleton_phenotype | 0.34177171 |
| 122 | MP0005164_abnormal_response_to | 0.33467822 |
| 123 | MP0002135_abnormal_kidney_morphology | 0.32523090 |
| 124 | MP0004145_abnormal_muscle_electrophysio | 0.32257102 |
| 125 | MP0005397_hematopoietic_system_phenotyp | 0.32153751 |
| 126 | MP0008260_abnormal_autophagy | 0.31337533 |
| 127 | MP0001501_abnormal_sleep_pattern | 0.31259681 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | T lymphocytopenia (HP:0005403) | 9.65930308 |
| 2 | Abnormality of T cell number (HP:0011839) | 9.29460213 |
| 3 | Severe combined immunodeficiency (HP:0004430) | 7.25388662 |
| 4 | Combined immunodeficiency (HP:0005387) | 6.79557420 |
| 5 | Abnormality of T cells (HP:0002843) | 6.16521221 |
| 6 | Nasal polyposis (HP:0100582) | 6.02055498 |
| 7 | Recurrent bronchitis (HP:0002837) | 5.31499423 |
| 8 | Stomatitis (HP:0010280) | 5.19234420 |
| 9 | Increased IgM level (HP:0003496) | 4.96888683 |
| 10 | Thyroiditis (HP:0100646) | 4.95036697 |
| 11 | Abnormality of the nasal mucosa (HP:0000433) | 4.91227289 |
| 12 | Myositis (HP:0100614) | 4.84585663 |
| 13 | IgG deficiency (HP:0004315) | 4.80356403 |
| 14 | Abnormality of macrophages (HP:0004311) | 4.39256877 |
| 15 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.38609603 |
| 16 | Retrobulbar optic neuritis (HP:0100654) | 4.31026259 |
| 17 | Optic neuritis (HP:0100653) | 4.31026259 |
| 18 | Abnormality of eosinophils (HP:0001879) | 4.10725183 |
| 19 | Recurrent fungal infections (HP:0002841) | 4.09916389 |
| 20 | Eczematoid dermatitis (HP:0000976) | 4.09071633 |
| 21 | Chronic otitis media (HP:0000389) | 4.08510996 |
| 22 | Recurrent cutaneous fungal infections (HP:0011370) | 4.02697350 |
| 23 | Chronic mucocutaneous candidiasis (HP:0002728) | 4.02697350 |
| 24 | Chronic diarrhea (HP:0002028) | 3.91512567 |
| 25 | Aplastic anemia (HP:0001915) | 3.84561509 |
| 26 | Joint swelling (HP:0001386) | 3.83264556 |
| 27 | Orchitis (HP:0100796) | 3.78649745 |
| 28 | Hypoplasia of the thymus (HP:0000778) | 3.78379130 |
| 29 | IgM deficiency (HP:0002850) | 3.67063806 |
| 30 | Panhypogammaglobulinemia (HP:0003139) | 3.63124822 |
| 31 | Leukocytosis (HP:0001974) | 3.62084340 |
| 32 | Autoimmune hemolytic anemia (HP:0001890) | 3.59496700 |
| 33 | Recurrent abscess formation (HP:0002722) | 3.57273384 |
| 34 | Recurrent viral infections (HP:0004429) | 3.40285578 |
| 35 | Gastrointestinal infarctions (HP:0005244) | 3.33213365 |
| 36 | Lymphopenia (HP:0001888) | 3.32208087 |
| 37 | Keratoconjunctivitis sicca (HP:0001097) | 3.26228003 |
| 38 | Abnormality of T cell physiology (HP:0011840) | 3.23979036 |
| 39 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 3.21004328 |
| 40 | Pulmonary infiltrates (HP:0002113) | 3.19814241 |
| 41 | Hemoptysis (HP:0002105) | 3.15570604 |
| 42 | Meningitis (HP:0001287) | 3.14235714 |
| 43 | Encephalitis (HP:0002383) | 3.10686895 |
| 44 | Pustule (HP:0200039) | 3.06078669 |
| 45 | Vasculitis (HP:0002633) | 3.01491725 |
| 46 | Hypoproteinemia (HP:0003075) | 3.00139456 |
| 47 | Bronchitis (HP:0012387) | 2.97222476 |
| 48 | Keratoconjunctivitis (HP:0001096) | 2.94196512 |
| 49 | Gastrointestinal stroma tumor (HP:0100723) | 2.91838884 |
| 50 | Hypergammaglobulinemia (HP:0010702) | 2.89205966 |
| 51 | IgA deficiency (HP:0002720) | 2.88733009 |
| 52 | Chronic obstructive pulmonary disease (HP:0006510) | 2.79951795 |
| 53 | Obstructive lung disease (HP:0006536) | 2.79951795 |
| 54 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.79759840 |
| 55 | Abnormality of the prostate (HP:0008775) | 2.78410390 |
| 56 | Recurrent sinusitis (HP:0011108) | 2.78012879 |
| 57 | Inflammation of the large intestine (HP:0002037) | 2.72219695 |
| 58 | Urticaria (HP:0001025) | 2.71171629 |
| 59 | Acute hepatic failure (HP:0006554) | 2.68919112 |
| 60 | Recurrent skin infections (HP:0001581) | 2.66872120 |
| 61 | Agammaglobulinemia (HP:0004432) | 2.66349433 |
| 62 | Mediastinal lymphadenopathy (HP:0100721) | 2.64847786 |
| 63 | Arterial thrombosis (HP:0004420) | 2.63880323 |
| 64 | Abnormality of B cell number (HP:0010975) | 2.59868759 |
| 65 | B lymphocytopenia (HP:0010976) | 2.59868759 |
| 66 | Eosinophilia (HP:0001880) | 2.59176343 |
| 67 | Gastrointestinal inflammation (HP:0004386) | 2.55517282 |
| 68 | Gangrene (HP:0100758) | 2.53871909 |
| 69 | Pulmonary embolism (HP:0002204) | 2.52009467 |
| 70 | Renal cortical cysts (HP:0000803) | 2.47321177 |
| 71 | Lymphoma (HP:0002665) | 2.44431332 |
| 72 | Colitis (HP:0002583) | 2.43109392 |
| 73 | Hepatitis (HP:0012115) | 2.34710952 |
| 74 | Hypochromic anemia (HP:0001931) | 2.31158403 |
| 75 | Petechiae (HP:0000967) | 2.30529695 |
| 76 | Thrombocytosis (HP:0001894) | 2.30430720 |
| 77 | Recurrent bacterial skin infections (HP:0005406) | 2.29154697 |
| 78 | Anorexia (HP:0002039) | 2.27363452 |
| 79 | Autoimmune thrombocytopenia (HP:0001973) | 2.24880486 |
| 80 | Granulocytopenia (HP:0001913) | 2.24134974 |
| 81 | Spontaneous hematomas (HP:0007420) | 2.22942017 |
| 82 | Increased IgE level (HP:0003212) | 2.22320998 |
| 83 | Papilloma (HP:0012740) | 2.17638434 |
| 84 | Verrucae (HP:0200043) | 2.17638434 |
| 85 | Frequent falls (HP:0002359) | 2.17598793 |
| 86 | Abnormality of the fingertips (HP:0001211) | 2.17531012 |
| 87 | Sepsis (HP:0100806) | 2.17056808 |
| 88 | Chronic sinusitis (HP:0011109) | 2.15031440 |
| 89 | Polyneuropathy (HP:0001271) | 2.09027382 |
| 90 | Glomerulopathy (HP:0100820) | 2.02507337 |
| 91 | Prolonged bleeding time (HP:0003010) | 2.02457457 |
| 92 | Recurrent otitis media (HP:0000403) | 2.00220586 |
| 93 | Cellulitis (HP:0100658) | 1.99452403 |
| 94 | Chest pain (HP:0100749) | 1.98606233 |
| 95 | Epistaxis (HP:0000421) | 1.97008629 |
| 96 | Gingivitis (HP:0000230) | 1.96615159 |
| 97 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 1.91785813 |
| 98 | Hypochromic microcytic anemia (HP:0004840) | 1.91162830 |
| 99 | Ureteral stenosis (HP:0000071) | 1.90877077 |
| 100 | Gingival bleeding (HP:0000225) | 1.90430033 |
| 101 | Abnormality of the pleura (HP:0002103) | 1.89682729 |
| 102 | Restrictive lung disease (HP:0002091) | 1.88910048 |
| 103 | Basal cell carcinoma (HP:0002671) | 1.88098506 |
| 104 | Amaurosis fugax (HP:0100576) | 1.87288673 |
| 105 | Reduced antithrombin III activity (HP:0001976) | 1.87280302 |
| 106 | Prostate neoplasm (HP:0100787) | 1.87145788 |
| 107 | Keratitis (HP:0000491) | 1.85976959 |
| 108 | Arthralgia (HP:0002829) | 1.84318356 |
| 109 | Diplopia (HP:0000651) | 1.82944156 |
| 110 | Abnormality of binocular vision (HP:0011514) | 1.82944156 |
| 111 | Conjugated hyperbilirubinemia (HP:0002908) | 1.80508253 |
| 112 | Pulmonary fibrosis (HP:0002206) | 1.80358476 |
| 113 | Microcytic anemia (HP:0001935) | 1.76507624 |
| 114 | Cheilitis (HP:0100825) | 1.73677986 |
| 115 | Skin rash (HP:0000988) | 1.71811776 |
| 116 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.70895917 |
| 117 | Aortic dissection (HP:0002647) | 1.69999220 |
| 118 | Abnormal platelet volume (HP:0011876) | 1.69973016 |
| 119 | Emphysema (HP:0002097) | 1.69678017 |
| 120 | Ureteral obstruction (HP:0006000) | 1.69129338 |
| 121 | Abnormality of the pericardium (HP:0001697) | 1.67731608 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TXK | 6.19635635 |
| 2 | MAP4K1 | 5.04942165 |
| 3 | ITK | 4.18360525 |
| 4 | ZAP70 | 3.17006630 |
| 5 | IKBKE | 3.11526438 |
| 6 | JAK3 | 3.02393254 |
| 7 | RIPK4 | 3.01839464 |
| 8 | JAK1 | 3.00333730 |
| 9 | TYK2 | 2.97101526 |
| 10 | CSK | 2.89746628 |
| 11 | FGFR4 | 2.84982739 |
| 12 | TESK2 | 2.67734264 |
| 13 | STK10 | 2.54623223 |
| 14 | TBK1 | 2.26734498 |
| 15 | MAP3K12 | 2.15668708 |
| 16 | LCK | 2.11745331 |
| 17 | BUB1 | 2.05735843 |
| 18 | FGFR3 | 1.88932343 |
| 19 | IRAK4 | 1.88447434 |
| 20 | MAP3K14 | 1.84653358 |
| 21 | BTK | 1.84308175 |
| 22 | NLK | 1.67257204 |
| 23 | KDR | 1.61729523 |
| 24 | TEC | 1.61521235 |
| 25 | GRK6 | 1.61500218 |
| 26 | MAP3K11 | 1.59800847 |
| 27 | ERN1 | 1.51742832 |
| 28 | BLK | 1.48893941 |
| 29 | HCK | 1.43008797 |
| 30 | MAP2K6 | 1.42377969 |
| 31 | MST4 | 1.41868595 |
| 32 | SYK | 1.30660757 |
| 33 | PRKCQ | 1.28964399 |
| 34 | KIT | 1.20882722 |
| 35 | PRKCH | 1.19915469 |
| 36 | PRPF4B | 1.18650418 |
| 37 | MELK | 1.13856932 |
| 38 | LYN | 1.01640128 |
| 39 | NME2 | 0.99921431 |
| 40 | LRRK2 | 0.98521782 |
| 41 | RPS6KA4 | 0.97157874 |
| 42 | CLK1 | 0.94545637 |
| 43 | CAMKK2 | 0.94282451 |
| 44 | IKBKB | 0.92025949 |
| 45 | CAMKK1 | 0.84548441 |
| 46 | TESK1 | 0.83167218 |
| 47 | JAK2 | 0.79778232 |
| 48 | ACVR1B | 0.79114620 |
| 49 | SMG1 | 0.76754490 |
| 50 | NEK9 | 0.72766361 |
| 51 | FES | 0.72618251 |
| 52 | MAP3K13 | 0.70452628 |
| 53 | CSF1R | 0.69693979 |
| 54 | FGR | 0.66089637 |
| 55 | TNK2 | 0.65877380 |
| 56 | MAPKAPK3 | 0.65351996 |
| 57 | VRK1 | 0.62574183 |
| 58 | BMPR2 | 0.61459247 |
| 59 | MARK3 | 0.60883319 |
| 60 | PIK3CG | 0.58777038 |
| 61 | SCYL2 | 0.57491422 |
| 62 | MAP2K3 | 0.56441931 |
| 63 | IRAK1 | 0.56427339 |
| 64 | PIM1 | 0.56004886 |
| 65 | ADRBK2 | 0.54634234 |
| 66 | MAP3K1 | 0.54268375 |
| 67 | FYN | 0.53095033 |
| 68 | TGFBR2 | 0.52996540 |
| 69 | INSR | 0.50037103 |
| 70 | IRAK2 | 0.49974024 |
| 71 | TAOK2 | 0.49702621 |
| 72 | MAP3K10 | 0.48820718 |
| 73 | MAP3K7 | 0.47471096 |
| 74 | EPHA3 | 0.47458183 |
| 75 | SIK2 | 0.46234458 |
| 76 | MAPK11 | 0.46071897 |
| 77 | CDK9 | 0.45326606 |
| 78 | VRK2 | 0.45028942 |
| 79 | MAP3K3 | 0.44391510 |
| 80 | IGF1R | 0.42527261 |
| 81 | MAPKAPK2 | 0.41664589 |
| 82 | MAPK7 | 0.41599509 |
| 83 | TAOK3 | 0.40187580 |
| 84 | MAPK12 | 0.39655412 |
| 85 | TYRO3 | 0.39462838 |
| 86 | PDK1 | 0.39294166 |
| 87 | MAP3K5 | 0.39289321 |
| 88 | BCKDK | 0.39248143 |
| 89 | EPHB1 | 0.38287152 |
| 90 | TLK1 | 0.36233777 |
| 91 | CDK8 | 0.35646567 |
| 92 | CDK4 | 0.34240749 |
| 93 | HIPK2 | 0.33512436 |
| 94 | RPS6KA5 | 0.33344045 |
| 95 | TTN | 0.32238386 |
| 96 | PDGFRB | 0.31548211 |
| 97 | CSNK1A1L | 0.30023824 |
| 98 | MYLK | 0.29204355 |
| 99 | PRKCD | 0.27854383 |
| 100 | CHUK | 0.26115867 |
| 101 | PRKD2 | 0.25735712 |
| 102 | STK16 | 0.24452928 |
| 103 | TSSK6 | 0.23874221 |
| 104 | NUAK1 | 0.22537664 |
| 105 | DAPK3 | 0.22520872 |
| 106 | ABL1 | 0.22306176 |
| 107 | SRC | 0.22000021 |
| 108 | RAF1 | 0.19794163 |
| 109 | ZAK | 0.19756848 |
| 110 | FGFR1 | 0.19448723 |
| 111 | TAOK1 | 0.18444704 |
| 112 | MAP2K2 | 0.17273412 |
| 113 | MAP3K8 | 0.16850803 |
| 114 | GRK7 | 0.16299134 |
| 115 | DMPK | 0.16198816 |
| 116 | EIF2AK3 | 0.15797373 |
| 117 | SIK3 | 0.15614665 |
| 118 | PKN2 | 0.15589754 |
| 119 | MAPK3 | 0.15356974 |
| 120 | PRKCB | 0.15022259 |
| 121 | NME1 | 0.14786692 |
| 122 | EEF2K | 0.13885741 |
| 123 | ALK | 0.12845660 |
| 124 | PTK6 | 0.12744375 |
| 125 | PASK | 0.12582349 |
| 126 | STK4 | 0.11930170 |
| 127 | TGFBR1 | 0.11492115 |
| 128 | ILK | 0.11200352 |
| 129 | CSNK1A1 | 0.10402593 |
| 130 | GSK3A | 0.10314027 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 6.53132517 |
| 2 | Graft-versus-host disease_Homo sapiens_hsa05332 | 5.44149560 |
| 3 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 4.41042176 |
| 4 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 3.90646484 |
| 5 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 3.77302572 |
| 6 | Antigen processing and presentation_Homo sapiens_hsa04612 | 3.67070842 |
| 7 | Allograft rejection_Homo sapiens_hsa05330 | 3.11940577 |
| 8 | Measles_Homo sapiens_hsa05162 | 2.72949705 |
| 9 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.32616019 |
| 10 | Viral myocarditis_Homo sapiens_hsa05416 | 2.14019330 |
| 11 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.13902081 |
| 12 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.82270698 |
| 13 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.78425968 |
| 14 | Leishmaniasis_Homo sapiens_hsa05140 | 1.77299587 |
| 15 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.74715987 |
| 16 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.63488212 |
| 17 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.59093104 |
| 18 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.58844265 |
| 19 | Malaria_Homo sapiens_hsa05144 | 1.47360242 |
| 20 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.46435857 |
| 21 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.43368642 |
| 22 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.42670484 |
| 23 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.40614044 |
| 24 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.40275295 |
| 25 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.38807055 |
| 26 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.31701390 |
| 27 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.27699627 |
| 28 | * Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.13457416 |
| 29 | * Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.09008000 |
| 30 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.06673478 |
| 31 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.04402895 |
| 32 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.02039822 |
| 33 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.98096173 |
| 34 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.98043229 |
| 35 | Hepatitis B_Homo sapiens_hsa05161 | 0.95873559 |
| 36 | Shigellosis_Homo sapiens_hsa05131 | 0.92935128 |
| 37 | Influenza A_Homo sapiens_hsa05164 | 0.91162857 |
| 38 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.89191361 |
| 39 | HTLV-I infection_Homo sapiens_hsa05166 | 0.89053446 |
| 40 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.83070617 |
| 41 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.79876169 |
| 42 | Apoptosis_Homo sapiens_hsa04210 | 0.79592666 |
| 43 | Colorectal cancer_Homo sapiens_hsa05210 | 0.76708644 |
| 44 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.75896679 |
| 45 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.75343850 |
| 46 | Other glycan degradation_Homo sapiens_hsa00511 | 0.66455404 |
| 47 | Proteasome_Homo sapiens_hsa03050 | 0.63219765 |
| 48 | Salmonella infection_Homo sapiens_hsa05132 | 0.62304067 |
| 49 | Phagosome_Homo sapiens_hsa04145 | 0.60905963 |
| 50 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.60622086 |
| 51 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.59222309 |
| 52 | Asthma_Homo sapiens_hsa05310 | 0.59040439 |
| 53 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.58646953 |
| 54 | Tuberculosis_Homo sapiens_hsa05152 | 0.56193005 |
| 55 | Mismatch repair_Homo sapiens_hsa03430 | 0.56084257 |
| 56 | Platelet activation_Homo sapiens_hsa04611 | 0.55454085 |
| 57 | Hepatitis C_Homo sapiens_hsa05160 | 0.53509631 |
| 58 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.53316390 |
| 59 | DNA replication_Homo sapiens_hsa03030 | 0.53064361 |
| 60 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.50776052 |
| 61 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.50730731 |
| 62 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.50274487 |
| 63 | Legionellosis_Homo sapiens_hsa05134 | 0.50069656 |
| 64 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.47900995 |
| 65 | Base excision repair_Homo sapiens_hsa03410 | 0.46449070 |
| 66 | Ribosome_Homo sapiens_hsa03010 | 0.43210122 |
| 67 | Endocytosis_Homo sapiens_hsa04144 | 0.41184194 |
| 68 | RNA degradation_Homo sapiens_hsa03018 | 0.40603722 |
| 69 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.40546633 |
| 70 | Adherens junction_Homo sapiens_hsa04520 | 0.39956835 |
| 71 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.39938319 |
| 72 | Pertussis_Homo sapiens_hsa05133 | 0.38644726 |
| 73 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.38425025 |
| 74 | Alcoholism_Homo sapiens_hsa05034 | 0.35418877 |
| 75 | Homologous recombination_Homo sapiens_hsa03440 | 0.33118464 |
| 76 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.31095749 |
| 77 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.29066909 |
| 78 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.28436392 |
| 79 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.28166733 |
| 80 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.27234062 |
| 81 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.26224105 |
| 82 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.26003770 |
| 83 | Lysosome_Homo sapiens_hsa04142 | 0.25500550 |
| 84 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.25453371 |
| 85 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.25386576 |
| 86 | Spliceosome_Homo sapiens_hsa03040 | 0.24562908 |
| 87 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.24157648 |
| 88 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.23932079 |
| 89 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.18184223 |
| 90 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.18167662 |
| 91 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.16094277 |
| 92 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.14012584 |
| 93 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.12890367 |
| 94 | Basal transcription factors_Homo sapiens_hsa03022 | 0.12231615 |
| 95 | RNA polymerase_Homo sapiens_hsa03020 | 0.11907918 |
| 96 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.11561658 |
| 97 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.11097976 |
| 98 | ABC transporters_Homo sapiens_hsa02010 | 0.11026824 |
| 99 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.10300128 |
| 100 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.10199064 |
| 101 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.09969034 |
| 102 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.09709013 |
| 103 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.09701472 |
| 104 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.09624791 |
| 105 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.07815002 |
| 106 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.07342722 |
| 107 | Cell cycle_Homo sapiens_hsa04110 | 0.06649880 |
| 108 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.04641358 |
| 109 | Focal adhesion_Homo sapiens_hsa04510 | 0.02472429 |
| 110 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.02146257 |
| 111 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.02004833 |
| 112 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.01042056 |
| 113 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.00792217 |
| 114 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.00388887 |
| 115 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | -0.0504025 |
| 116 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | -0.0463270 |
| 117 | Prion diseases_Homo sapiens_hsa05020 | -0.0461895 |
| 118 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.0450294 |
| 119 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | -0.0351533 |
| 120 | Renal cell carcinoma_Homo sapiens_hsa05211 | -0.0169196 |
| 121 | Insulin resistance_Homo sapiens_hsa04931 | -0.0035190 |
| 122 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | -0.0034590 |

